The new treatment paradigm and the role of carbapenems
- 28 February 2009
- journal article
- review article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 33 (2), 105.e1-105.e8
- https://doi.org/10.1016/j.ijantimicag.2008.07.023
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 resultsDiagnostic Microbiology and Infectious Disease, 2008
- Predictors of 30-Day Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: Impact of Delayed Appropriate Antibiotic SelectionAntimicrobial Agents and Chemotherapy, 2007
- Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial TreatmentAntimicrobial Agents and Chemotherapy, 2007
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006
- Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing EnterobacteriaceaeAntimicrobial Agents and Chemotherapy, 2006
- Antibacterial Dosing in Intensive CareClinical Pharmacokinetics, 2006
- An overview of the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program: 1997–2004Diagnostic Microbiology and Infectious Disease, 2005
- Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase– and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997–2004)Diagnostic Microbiology and Infectious Disease, 2005
- Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002–2004Diagnostic Microbiology and Infectious Disease, 2005
- Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002Diagnostic Microbiology and Infectious Disease, 2004